Logo

Michael Goldberg, Danong Chen

Apr 23, 2008
Premium
Michael Goldberg plans to resign from his position on the board of directors of Genomic Health as of the next annual stockholders meeting in May, according to a company filing with the US Securities and Exchange Commission last week.
 
 
Danong Chen has been elected as the new president and CEO of Theranostics Health. Chen was previously the president and CEO of Tanox, a publicly held biopharmaceutical company that was acquired by Genentech in 2007.
 
Prior to her tenure at Tanox she served as a manager in the health care practice section at Arthur D. Little. Chen also holds a PhD from Baylor College of Medicine as well as an MBA from Arthur D. Little School of Management in Boston.

Filed under

Diagnostics
Breaking News
The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.